Drug profile · INN
hexachlorophene
SOY-DOME
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
hexachlorophene (SOY-DOME) is an FDA-listed pharmaceutical active ingredient. Associated with ADIAL PHARMACEUTICALS, INC.. Route of administration: topical. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12162837
Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same
granted -
US 12059418
Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
granted -
US 11884932
In vitro production of medial ganglionic eminence precursor cells
granted -
US 11851503
Antiplasmodial compounds
granted -
US 11725217
Methods to enhance myocardial regeneration and/or repair
granted -
US 11530240
Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering
granted -
US 11319290
Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same
granted -
US 11230569
Antiplasmodial compounds
granted
Frequently asked questions
What is hexachlorophene?
hexachlorophene (SOY-DOME) is an FDA-listed pharmaceutical active ingredient. Associated with ADIAL PHARMACEUTICALS, INC.. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for hexachlorophene?
SOY-DOME is a marketed brand name for hexachlorophene. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hexachlorophene?
hexachlorophene has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.